Investigating the Role of BAFF and Its Receptors in Renal Transplant Recipients with Chronic Antibody-Mediated Rejection
Background. Kidney transplantation is the best treatment option for end stage renal disease (ESRD), but graft rejection is still a big obstacle that occurs in spite of immunosuppressive therapy. B cells are considered as the major reason for renal graft rejection because of antibody production. Due...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2021/6654992 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850159901693706240 |
|---|---|
| author | Shima Afzali Saeedeh Salehi Abbas Shahi Marzie Esmaeili Samad Farashi Bonab Azin Peykari Farzaneh Bagherpour Bita Ansaripour Tayebeh Soleimanian Fatemeh Pour-Reza-Gholi Aliakbar Amirzargar |
| author_facet | Shima Afzali Saeedeh Salehi Abbas Shahi Marzie Esmaeili Samad Farashi Bonab Azin Peykari Farzaneh Bagherpour Bita Ansaripour Tayebeh Soleimanian Fatemeh Pour-Reza-Gholi Aliakbar Amirzargar |
| author_sort | Shima Afzali |
| collection | DOAJ |
| description | Background. Kidney transplantation is the best treatment option for end stage renal disease (ESRD), but graft rejection is still a big obstacle that occurs in spite of immunosuppressive therapy. B cells are considered as the major reason for renal graft rejection because of antibody production. Due to their roles in B cell function, we intended to evaluate the B cell activating factor (BAFF) and its receptors including BAFF receptor (BAFF-R), B cell maturation antigen (BCMA), and transmembrane activator and cyclophilin ligand interactor (TACI) in renal transplant patients. Method. The study included 40 kidney allograft patients with cAMR, 40 stable kidney allograft patients, and 8 healthy volunteers with normal kidney function. The percentage and absolute number of CD19+ B cells were analyzed by flow cytometry, the serum level of BAFF was analyzed by ELISA, and mRNA expressions of BAFF and BAFF receptors (BAFF-R, BCMA, and TACI) were measured using quantitative real-time PCR. Results. The percentage and the absolute number of B cells decreased significantly in stable and cAMR patients compared to healthy individuals. The serum level and gene expression of BAFF, as well as the mRNA level of BCMA, were increased significantly in both cAMR and stable patients compared to healthy volunteers. There was an overexpression of TACI mRNA in cAMR patients compared to stable patients. Conclusions. Both soluble protein and mRNA transcript of BAFF increased in transplant recipients. However, BAFF neither at the serum level nor at the mRNA transcript level cannot be a good biomarker for the prediction of cAMR. In addition, expression of TACI, compared to other receptors of BAFF, confers a potential to be used in distinguishing cAMR and stable kidney transplant patients. |
| format | Article |
| id | doaj-art-b21190ef32154b26acd7c77d0e42e0ce |
| institution | OA Journals |
| issn | 2314-8861 2314-7156 |
| language | English |
| publishDate | 2021-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Immunology Research |
| spelling | doaj-art-b21190ef32154b26acd7c77d0e42e0ce2025-08-20T02:23:19ZengWileyJournal of Immunology Research2314-88612314-71562021-01-01202110.1155/2021/66549926654992Investigating the Role of BAFF and Its Receptors in Renal Transplant Recipients with Chronic Antibody-Mediated RejectionShima Afzali0Saeedeh Salehi1Abbas Shahi2Marzie Esmaeili3Samad Farashi Bonab4Azin Peykari5Farzaneh Bagherpour6Bita Ansaripour7Tayebeh Soleimanian8Fatemeh Pour-Reza-Gholi9Aliakbar Amirzargar10Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, IranDepartment of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, IranDepartment of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, IranDepartment of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, IranDepartment of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, IranChronic Kidney Disease Research Center, Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, IranOrgan Procurement Unit, Sina Hospital, Tehran University of Medical Sciences, Tehran, IranDepartment of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, IranNephrology Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, IranChronic Kidney Disease Research Center, Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, IranDepartment of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, IranBackground. Kidney transplantation is the best treatment option for end stage renal disease (ESRD), but graft rejection is still a big obstacle that occurs in spite of immunosuppressive therapy. B cells are considered as the major reason for renal graft rejection because of antibody production. Due to their roles in B cell function, we intended to evaluate the B cell activating factor (BAFF) and its receptors including BAFF receptor (BAFF-R), B cell maturation antigen (BCMA), and transmembrane activator and cyclophilin ligand interactor (TACI) in renal transplant patients. Method. The study included 40 kidney allograft patients with cAMR, 40 stable kidney allograft patients, and 8 healthy volunteers with normal kidney function. The percentage and absolute number of CD19+ B cells were analyzed by flow cytometry, the serum level of BAFF was analyzed by ELISA, and mRNA expressions of BAFF and BAFF receptors (BAFF-R, BCMA, and TACI) were measured using quantitative real-time PCR. Results. The percentage and the absolute number of B cells decreased significantly in stable and cAMR patients compared to healthy individuals. The serum level and gene expression of BAFF, as well as the mRNA level of BCMA, were increased significantly in both cAMR and stable patients compared to healthy volunteers. There was an overexpression of TACI mRNA in cAMR patients compared to stable patients. Conclusions. Both soluble protein and mRNA transcript of BAFF increased in transplant recipients. However, BAFF neither at the serum level nor at the mRNA transcript level cannot be a good biomarker for the prediction of cAMR. In addition, expression of TACI, compared to other receptors of BAFF, confers a potential to be used in distinguishing cAMR and stable kidney transplant patients.http://dx.doi.org/10.1155/2021/6654992 |
| spellingShingle | Shima Afzali Saeedeh Salehi Abbas Shahi Marzie Esmaeili Samad Farashi Bonab Azin Peykari Farzaneh Bagherpour Bita Ansaripour Tayebeh Soleimanian Fatemeh Pour-Reza-Gholi Aliakbar Amirzargar Investigating the Role of BAFF and Its Receptors in Renal Transplant Recipients with Chronic Antibody-Mediated Rejection Journal of Immunology Research |
| title | Investigating the Role of BAFF and Its Receptors in Renal Transplant Recipients with Chronic Antibody-Mediated Rejection |
| title_full | Investigating the Role of BAFF and Its Receptors in Renal Transplant Recipients with Chronic Antibody-Mediated Rejection |
| title_fullStr | Investigating the Role of BAFF and Its Receptors in Renal Transplant Recipients with Chronic Antibody-Mediated Rejection |
| title_full_unstemmed | Investigating the Role of BAFF and Its Receptors in Renal Transplant Recipients with Chronic Antibody-Mediated Rejection |
| title_short | Investigating the Role of BAFF and Its Receptors in Renal Transplant Recipients with Chronic Antibody-Mediated Rejection |
| title_sort | investigating the role of baff and its receptors in renal transplant recipients with chronic antibody mediated rejection |
| url | http://dx.doi.org/10.1155/2021/6654992 |
| work_keys_str_mv | AT shimaafzali investigatingtheroleofbaffanditsreceptorsinrenaltransplantrecipientswithchronicantibodymediatedrejection AT saeedehsalehi investigatingtheroleofbaffanditsreceptorsinrenaltransplantrecipientswithchronicantibodymediatedrejection AT abbasshahi investigatingtheroleofbaffanditsreceptorsinrenaltransplantrecipientswithchronicantibodymediatedrejection AT marzieesmaeili investigatingtheroleofbaffanditsreceptorsinrenaltransplantrecipientswithchronicantibodymediatedrejection AT samadfarashibonab investigatingtheroleofbaffanditsreceptorsinrenaltransplantrecipientswithchronicantibodymediatedrejection AT azinpeykari investigatingtheroleofbaffanditsreceptorsinrenaltransplantrecipientswithchronicantibodymediatedrejection AT farzanehbagherpour investigatingtheroleofbaffanditsreceptorsinrenaltransplantrecipientswithchronicantibodymediatedrejection AT bitaansaripour investigatingtheroleofbaffanditsreceptorsinrenaltransplantrecipientswithchronicantibodymediatedrejection AT tayebehsoleimanian investigatingtheroleofbaffanditsreceptorsinrenaltransplantrecipientswithchronicantibodymediatedrejection AT fatemehpourrezagholi investigatingtheroleofbaffanditsreceptorsinrenaltransplantrecipientswithchronicantibodymediatedrejection AT aliakbaramirzargar investigatingtheroleofbaffanditsreceptorsinrenaltransplantrecipientswithchronicantibodymediatedrejection |